084990.KQ
Helixmith Co., Ltd
KOE · Healthcare · Biotechnology · KR
KRW 2,955.00
+0.34%Year over year
Reported trailing growth
- Revenue
- -51.4%
- EBITDA
- -54.0%
- EBIT
- +15.7%
- EPS
- +80.0%
- Free cash flow
- +69.2%
- Operating cash flow
- +69.2%
Forward estimates
Based on analyst estimates
- Revenue
- +85.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -2.5%
- EBITDA
- +27.2%
- EBIT
- +44.9%
- Net income
- +97.2%
- EPS
- +97.1%
- Free cash flow
- +81.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026